O-t-Butyltartrondiamid | 34604-23-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: O-t-Butyltartrondiamid
• 英文别名: 2-[(2-Methylpropan-2-yl)oxy]propanediamide
• CAS: 34604-23-4
• 化学式: C₇H₁₄N₂O₃
• 分子量: 174.2
• InChiKey: XPIUNEZSQFPRAX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  95.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  tert.Butoxymalonsaeure-dimethylester 在 ammonium hydroxide 作用下， 生成 O-t-Butyltartrondiamid
  参考文献：
  名称：

  Liwschitz,Y. et al., Israel Journal of Chemistry, 1971, vol. 9, p. 89 - 103

  摘要：

  DOI：

文献信息

• Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors
  申请人：Chang Han-Ting

  公开号：US20070135385A1

  公开（公告）日：2007-06-14

  Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.

  吲哚和与吲哚相关的化合物、组合物以及方法被披露。发明中的这些化合物作为磷脂酶抑制剂非常有用。发明中的这些化合物和组合物用于治疗动物受试者中的磷脂酶相关状况，例如胰岛素相关、体重相关和/或胆固醇相关状况。
• AZAINDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS
  申请人：Chang Han-Ting

  公开号：US20090239896A1

  公开（公告）日：2009-09-24

  Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject. The compounds include azaindoles of the formula below [insert FIG. 6 c ] in which at least one of CR4, CR5, CR6 and CR7 is replaced by N, and the groups R1-R7 are defined as in claim 1.

  本发明涉及吲哚及其相关化合物、组合物和方法。本发明的化合物可用作磷脂酶抑制剂。本发明的化合物和组合物可用于治疗磷脂酶相关疾病，例如动物主体中的胰岛素相关、体重相关和/或胆固醇相关疾病。化合物包括以下式子中的氮杂吲哚[插入FIG.6c]，其中CR4、CR5、CR6和CR7中的至少一个被N替换，且R1-R7基团如权利要求1所定义。
• Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
  申请人：Chang Han-Ting

  公开号：US20070135383A1

  公开（公告）日：2007-06-14

  The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.

  本发明提供了治疗磷脂酶相关疾病的方法和组合物。具体地，本发明提供了一种用于治疗动物主体中的胰岛素相关、体重相关和/或胆固醇相关疾病的方法。该方法通常涉及在胃肠道腔中定位的非吸收和/或外流的磷脂酶A2抑制剂的给药。
• INDOLE COMPOUNDS HAVING C4-AMIDE SUBSTITUENTS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS
  申请人：Chang Han-Ting

  公开号：US20090306171A1

  公开（公告）日：2009-12-10

  Indole and indole-related compounds according to the formula (I) or (II) optionally having additional heteroatoms, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject. Formula (I), formula (II). R 4 being a moiety represented by formula (C4-II-C), R 3 being a moiety represented by formula (C3-I or C3-II).

  本发明揭示了具有公式（I）或（II）的吲哚和吲哚相关化合物，可选择具有额外杂原子，以及组合物和方法。本发明的化合物可用作磷脂酶抑制剂。本发明的化合物和组合物可用于治疗磷脂酶相关疾病，例如动物体内的胰岛素相关、体重相关和/或胆固醇相关疾病。其中，公式（I）和公式（II）中，R4是由公式（C4-II-C）表示的基团，R3是由公式（C3-I或C3-II）表示的基团。
• US7666898B2
  申请人：——

  公开号：US7666898B2

  公开（公告）日：2010-02-23